Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.

Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.

Item
http://www.wikidata.org/entity/Q36758305
Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance.Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection modelPharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection modelEvaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.A review of the pharmacokinetics and pharmacodynamics of aztreonam.Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureus.Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro.Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.Amikacin Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis in Pediatric Cancer Patients.
P2860

Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.

Item
http://www.wikidata.org/entity/Q36758305
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Pharmacodynamics of once-daily ...... n an in vitro infection model.
@ast
Pharmacodynamics of once-daily ...... n an in vitro infection model.
@en
type
label
Pharmacodynamics of once-daily ...... n an in vitro infection model.
@ast
Pharmacodynamics of once-daily ...... n an in vitro infection model.
@en
prefLabel
Pharmacodynamics of once-daily ...... n an in vitro infection model.
@ast
Pharmacodynamics of once-daily ...... n an in vitro infection model.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Pharmacodynamics of once-daily ...... n an in vitro infection model.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932